Sodium enoxaparin

DRUG2 trials

Sponsors

Cristália Produtos Químicos Farmacêuticos Ltda., Avexima Diol LLC

Conditions

Arthroplasty, Replacement, HipArthroplasty, Replacement, KneePreventionVenous ThromboembolismVenous Thromboembolism (VTE)

Phase 3

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

CompletedNCT01308528

Cristália Produtos Químicos Farmacêuticos Ltda.Venous Thromboembolism

Start: 2015-02-28End: 2017-04-30Updated: 2017-07-19

Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin

CompletedNCT07124819

Avexima Diol LLCArthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Prevention +1

Start: 2024-07-22End: 2025-01-14Updated: 2026-01-16